Although there is no cure for narcolepsy, medication and lifestyle changes can help manage the symptoms. Medicines that ...

Axsome Therapeutics, Inc. AXSM announced that the FDA has approved Symbravo (meloxicam and rizatriptan) for the acute ...

Meloxicam is a nonsteroidal, anti-inflammatory molecule developed with Axsome’s Molecular Solubility Enhanced Inclusion ...

The Driver and Vehicle Licensing Agency (DVLA) is warning drivers about various medical conditions that could affect their ability to drive. It urges individuals to declare any listed conditions to ...

Axsome Therapeutics, Inc. , a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, will host a virtual investor event and conference call today at ...

Selvaraju highlighted Axsome earlier in the week as a Top Pick within their coverage universe, reiterating the Buy rating and emphasizing the company's strengthened position following the FDA's green ...

However, if you have a medical condition that affects your driving but don't voluntarily give up your licence, you must inform the DVLA, which will decide if you can continue holding a driving licence ...